OLR1 and neoplasm: The lectin-type oxidized LDL receptor 1 (LOX-1) was identified as a surface marker exclusively expressed on LDNs/G-MDSCs, but not on HDNs in both the peripheral blood and tumors of cancer patients; in contrast, in tumor-bearing mice LOX-1 was not associated with LDNs/G-MDSC [104].